131 related articles for article (PubMed ID: 9368948)
1. Influence of short-term water deprivation on antipyrine disposition in calves.
Janus K; Muszczynski Z; Suszycka J
Res Vet Sci; 1997; 63(1):1-3. PubMed ID: 9368948
[TBL] [Abstract][Full Text] [Related]
2. Effect of age on the pharmacokinetics of antipyrine in calves.
Janus K; Suszycka J
Res Vet Sci; 1996 May; 60(3):234-7. PubMed ID: 8735513
[TBL] [Abstract][Full Text] [Related]
3. The effect of sex on antipyrine metabolism in cattle at different ages.
Janus K; Antoszek J
J Vet Pharmacol Ther; 1999 Jun; 22(3):163-9. PubMed ID: 10447826
[TBL] [Abstract][Full Text] [Related]
4. Effect of short-term starvation and water deprivation on pharmacokinetics of antipyrine in calves.
Janus K
Arch Vet Pol; 1992; 32(3-4):119-25. PubMed ID: 1339567
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of antipyrine in calves after intravenous and oral administration.
Janus K; Muszczynski Z; Suszycka J
J Vet Pharmacol Ther; 1996 Oct; 19(5):408-10. PubMed ID: 8905578
[No Abstract] [Full Text] [Related]
6. Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes.
Jiang SX; Bayón JE; Ferre I; Mao XZ; González-Gallego J
Vet Parasitol; 2000 Mar; 88(3-4):177-86. PubMed ID: 10714456
[TBL] [Abstract][Full Text] [Related]
7. The effect of cimetidine on antipyrine metabolism in calves.
Janus K; Suszycka J
J Vet Pharmacol Ther; 1997 Feb; 20(1):73-6. PubMed ID: 9049953
[No Abstract] [Full Text] [Related]
8. The effect of age and sex on metabolism and urinary excretion of antipyrine.
Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
[TBL] [Abstract][Full Text] [Related]
9. Effect of spironolactone on antipyrine metabolism in calves.
Janus K; Suszycka J
Res Vet Sci; 1996 Jul; 61(1):87-8. PubMed ID: 8819201
[TBL] [Abstract][Full Text] [Related]
10. The effect of water deprivation on the pharmacokinetics of antipyrine and sulphadimidine following intravenous administration in Nubian goats.
Elsheikh HA; Osman IA; Abdullah AS
Vet Res Commun; 1997 Nov; 21(8):587-97. PubMed ID: 9444081
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine disposition in the dehydrated camel.
Ben-Zvi Z; Rubin M; Van Creveld C; Yagil R
J Vet Pharmacol Ther; 1995 Apr; 18(2):137-40. PubMed ID: 7629928
[TBL] [Abstract][Full Text] [Related]
12. Antipyrine pharmacokinetics and urinary excretion in female horses.
Dyke TM; Sams RA; Hinchcliff KW
Am J Vet Res; 1998 Mar; 59(3):280-5. PubMed ID: 9522945
[TBL] [Abstract][Full Text] [Related]
13. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
[TBL] [Abstract][Full Text] [Related]
14. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
15. Disposition of antipyrine in patients with extensive metastatic liver disease.
Robertz-Vaupel GM; Lindecken KD; Edeki T; Funke C; Belwon S; Dengler HJ
Eur J Clin Pharmacol; 1992; 42(5):465-9. PubMed ID: 1606991
[TBL] [Abstract][Full Text] [Related]
16. Hepatic drug clearance in patients with mild cystic fibrosis.
Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE
Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
St Peter JV; Abul-Hajj Y; Awni WM
Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
[TBL] [Abstract][Full Text] [Related]
18. The effect of short-term starvation or water deprivation on caffeine pharmacokinetics in calves.
Janus K; Antoszek J; Suszycki S
Res Vet Sci; 2001 Apr; 70(2):109-13. PubMed ID: 11356089
[TBL] [Abstract][Full Text] [Related]
19. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
20. Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine.
Yang BB; Hounslow NJ; Sedman AJ; Forgue ST
J Clin Pharmacol; 1996 Apr; 36(4):356-60. PubMed ID: 8728350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]